During the past decade, INECO Neurociencias Oroño conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "INECO Neurociencias Oroño" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "INECO Neurociencias Oroño" are "COVID-19" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "INECO Neurociencias Oroño" in a lesser frequency.

Most popular intervention types in "INECO Neurociencias Oroño" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bamlanivimab" (1 trials), "Bebtelovimab" (1 trials), "Etesevimab" (1 trials) and "Tirzepatide" (1 trials). Other intervention names were less common.

The vast majority of trials in "INECO Neurociencias Oroño" are 2 trials for "All" genders.

Currently, there are NaN active trials in "INECO Neurociencias Oroño". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in INECO Neurociencias Oroño, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in INECO Neurociencias Oroño, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".